Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

5.60
BATS BZX Real-Time Price
As of 12:37pm ET
 -0.34 / -5.72%
Today’s Change
5.23
Today|||52-Week Range
21.22
-35.78%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close5.94
Today’s open5.86
Day’s range5.43 - 6.06
Volume344,362
Average volume (3 months)486,250
Market cap$310.9M
Dividend yield--
Data as of 12:37pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+7.49%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book2.20

Competitors

 Today’s
change
Today’s
% change
SPPISpectrum Pharmaceuti...-0.26-5.62%
CNCEConcert Pharmaceutic...-0.71-5.00%
ADMSAdamas Pharmaceutica...-0.50-3.28%
CMRXChimerix Inc-0.32-4.62%
Data as of 12:39pm ET, 02/08/2016

Financials

Next reporting dateFebruary 17, 2016
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
Chief Operating, Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts

Partner Offers